Clinical Trials Directory

Trials / Conditions / Relapsed or Refractory Acute Myeloid Leukemia (AML)

Relapsed or Refractory Acute Myeloid Leukemia (AML)

8 registered clinical trials studyying Relapsed or Refractory Acute Myeloid Leukemia (AML) — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patient
NCT07500753
The First Affiliated Hospital of Soochow UniversityN/A
RecruitingBCL2i CLAG-M in R/R Acute Myeloid Leukemia
NCT06660368
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
TerminatedA Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
NCT05345938
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1 / Phase 2
RecruitingA Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemi
NCT05241093
Tarapeutics Science Inc.Phase 2
RecruitingA Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
NCT05241106
Tarapeutics Science Inc.Phase 2
TerminatedAn Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and
NCT04113616
Kartos Therapeutics, Inc.Phase 1 / Phase 2
TerminatedStudy of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.
NCT03218683
AstraZenecaPhase 1
RecruitingStudy of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
NCT02074839
Institut de Recherches Internationales ServierPhase 1